[Use of Ditek in the treatment of patients with chronic obstructive bronchitis].
In moderate activity of inflammation observed in chronic obstructive bronchitis (COB) patients, ditek significantly improves external respiration and lesser circulation hemodynamics, inhibits lipid peroxidation and catabolism of cell receptors. COB with active inflammation required additional administration of antimicrobal medicine.
Moskalev
M N
MN
D000336:Aerosols; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use*; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D008176:Lung Volume Measurements; D008297:Male; D008875:Middle Aged; D011652:Pulmonary Circulation / Q000187:drug effects; D012119:Respiration / Q000187:drug effects
D000336:Aerosols; D004338:Drug Combinations; C078581:ditec; D005280:Fenoterol; D004205:Cromolyn Sodium